Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

After a Bumpy Few Months, Cronos Stock Is Back on the Move

By Chris Lau, InvestorPlace Contributor

Cronos may have $2 billion in cash but it is strategic in the way it spends that. So far the right moves are helping Cronos stock.

Why Ford Stock Is Undervalued

By Chris Lau, InvestorPlace Contributor

F has a solid lineup of upcoming hybrid and electric vehicles. Ford stock price today undervalues Ford's overall outlook.

Subscription Numbers Make iQiyi Stock Look Like a Great Buy Here

By Chris Lau, InvestorPlace Contributor

iQIYI stock is in danger of falling close to its opening IPO price of 2018, but strong subscription growth should end the stock's fall.

AT&T Stock Should Explode as 5G Launches

By Chris Lau, InvestorPlace Contributor

T stock is a perfect dividend-income name for investors willing to wait for the growth from 5G to play out. Why buy AT&T stock now?

Alibaba Stock Is Poised to Rise

By Chris Lau, InvestorPlace Contributor

Alibaba's growth is undeniable. Markets sold Alibaba stock as trade tensions mounted but BABA stock is immune from it.

Load More